Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Dow
Merck
Johnson and Johnson
Covington
Moodys
Daiichi Sankyo
Fuji
Express Scripts
QuintilesIMS

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075136

« Back to Dashboard

NDA 075136 describes VERAPAMIL HYDROCHLORIDE, which is a drug marketed by Mylan, Abraxis Pharm, Bedford, Hospira, Intl Medication, Luitpold, Marsam Pharms Llc, Smith And Nephew, Solopak, Exela Pharma Scs Llc, Apotex Corp, Cadila Pharms Ltd, Glenmark Generics, Ivax Sub Teva Pharms, Par Pharm, Pliva, Sun Pharm Inds Inc, Actavis Elizabeth, Heritage Pharms Inc, Mutual Pharm, Sandoz, Sun Pharm Industries, Warner Chilcott, and Watson Labs, and is included in fifty-four NDAs. It is available from thirty-six suppliers. Additional details are available on the VERAPAMIL HYDROCHLORIDE profile page.

The generic ingredient in VERAPAMIL HYDROCHLORIDE is verapamil hydrochloride. There are seventeen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.
Summary for 075136
Tradename:VERAPAMIL HYDROCHLORIDE
Applicant:Hospira
Ingredient:verapamil hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 075136
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VERAPAMIL HYDROCHLORIDE verapamil hydrochloride SOLUTION;INTRAVENOUS 075136 ANDA Hospira, Inc. 0409-9633 0409-9633-05 10 CARTON in 1 CONTAINER (0409-9633-05) > 1 SYRINGE, PLASTIC in 1 CARTON > 4 mL in 1 SYRINGE, PLASTIC
VERAPAMIL HYDROCHLORIDE verapamil hydrochloride SOLUTION;INTRAVENOUS 075136 ANDA General Injectables & Vaccines, Inc 52584-633 52584-633-05 1 BOX in 1 BAG (52584-633-05) > 1 SYRINGE in 1 BOX > 4 mL in 1 SYRINGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength5MG/2ML (2.5MG/ML)
Approval Date:Oct 20, 1998TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Express Scripts
Novartis
Cerilliant
Queensland Health
Daiichi Sankyo
UBS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot